Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.570
+0.110 (3.18%)
At close: Jun 11, 2026, 4:00 PM EDT
3.630
+0.060 (1.68%)
Pre-market: Jun 12, 2026, 7:41 AM EDT
Eledon Pharmaceuticals Market Cap
Eledon Pharmaceuticals has a market cap or net worth of $275.97 million as of June 12, 2026. Its market cap has increased by 46.30% in one year.
Market Cap
275.97M
Enterprise Value
165.44M
1-Year Change
46.30%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since May 11, 2017, Eledon Pharmaceuticals's market cap has increased from $44.66M to $275.97M, an increase of 517.93%. That is a compound annual growth rate of 22.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 267.47M | 135.71% |
| Dec 31, 2025 | 113.47M | -53.90% |
| Dec 31, 2024 | 246.13M | 465.07% |
| Dec 29, 2023 | 43.56M | 38.87% |
| Dec 30, 2022 | 31.37M | -50.29% |
| Dec 31, 2021 | 63.09M | -72.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 294.20M |
| Rocket Pharmaceuticals | 290.45M |
| Nautilus Biotechnology | 290.38M |
| Bicycle Therapeutics | 286.23M |
| Inhibikase Therapeutics | 284.61M |
| Nuvectis Pharma | 278.78M |
| Armata Pharmaceuticals | 274.11M |
| Niagen Bioscience | 273.75M |